Model Number NEU_INS_STIMULATOR |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 05/27/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
Age/date of birth.This value is the average age of the patients reported in the article as specific patients could not be identified.Sex.This value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Date of event.Please note that this date is based off the date that the article was accepted for publication as the event dates were not provided in the published literature.The main component of the system.Other relevant device(s) are: product id: neu_unknown_lead, serial/lot #: unknown.Product id: neu_unknown_ext, serial/lot #: unknown.Deng, z., pan, y., zhang, c., zhang, j., qiu, x., zhan, s., li, d., sun, b.Subthalamic deep brain stimulation in patients with primary dystonia: a ten-year follow-up study.Parkinsonism relat disord.2018.Doi: 10.1016/j.Parkreldis.2018.05.024.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Summary: background: subthalamic deep brain stimulation (stn-dbs) is a promising intervention for primary dystonia; however, evidence regarding its efficacy is lacking.Thus, a long-term follow-up is indispensable.Objective: this trial was designed to examine the efficacy and consistency of subthalamic deep brain stimulation in patients with primary dystonia over the long term.Method: this was a retrospective study involving 14 patients with primary dystonia who underwent stn-dbs and consented to a follow-up of at least 10 years.The burke-fahn-marsden dystonia rating scale (bfmdrs) and 36-item short-form general health survey were employed, at five time points (pre-operation [baseline], 1 month post-operation, 1 year post-operation, 5 years post-operation, and last follow-up), to assess improvement of dystonic symptoms and changes in quality of life.Outcomes: all patients gained extensive clinical benefits from stn-dbs therapy, without experiencing serious adverse effects.Improvements of 59.0% at 1 month, 85.0% at 1 year, and 90.8% at 5 years after the operation, and up to 91.4% at the last follow-up, were demonstrated by movement evaluation with the bfmdrs.All patients achieved a substantial improvement in quality of life.Conclusion: subthalamic deep brain stimulation is an effective and persisting alternative to pallidal deep brain stimulation, and importantly, it is very safe even with extremely long-term chronic stimulation.Reported events: 1.2 patients with bilateral stn-dbs for primary dystonia experienced electrode displacement.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
|
|
Search Alerts/Recalls
|
|